Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Failure Mechanisms of Hollow Fiber Supported Ionic Liquid Membranes.

Zeh M, Wickramanayake S, Hopkinson D.

Membranes (Basel). 2016 Mar 23;6(2). pii: E21. doi: 10.3390/membranes6020021.

2.

Induction of premalignant host responses by cathepsin x/z-deficiency in Helicobacter pylori-infected mice.

Krueger S, Bernhardt A, Kalinski T, Baldensperger M, Zeh M, Teller A, Adolf D, Reinheckel T, Roessner A, Kuester D.

PLoS One. 2013 Jul 30;8(7):e70242. doi: 10.1371/journal.pone.0070242. Print 2013.

3.

Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.

Hörl WH, Locatelli F, Haag-Weber M, Ode M, Roth K; Epo-PASS study group.

Clin Nephrol. 2012 Jul;78(1):24-32.

PMID:
22732334
4.

Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.

Heidenreich S, Leistikow F, Zinn S, Baumann J, Atzeni A, Bajeski V, Dietzmann J, Dragoun GP; SUPRA Study Group.

Clin Drug Investig. 2012 Feb 1;32(2):99-110. doi: 10.2165/11594040-000000000-00000.

PMID:
22117178
5.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

6.

[Peritoneal splenosis 26 years after traumatic splenic rupture--rare differential diagnosis of a subepithelial gastric mass--case report and review of the literature].

Garlipp B, Zeh M, Scheidbach H, Kuester D, Lippert H.

Z Gastroenterol. 2011 Mar;49(3):344-9. doi: 10.1055/s-0029-1245619. Epub 2011 Mar 9. Review. German.

PMID:
21391166
7.
8.

Hydroxy-1-aryl-isochromans: protective compounds against lipid peroxidation and cellular nitrosative stress.

Zeh M, Lorenz P, Kreutzmann P, Schönfeld P.

Redox Rep. 2008;13(1):23-30. doi: 10.1179/135100008X259123.

PMID:
18284848
9.

[Nausea and confusion in a diabetic patient. Hyponatremia as an incidental finding].

Hohage H, Zeh M.

MMW Fortschr Med. 2006 Nov 9;148(45):50-1. German. No abstract available.

PMID:
17615750
10.

Natural and newly synthesized hydroxy-1-aryl-isochromans: a class of potential antioxidants and radical scavengers.

Lorenz P, Zeh M, Martens-Lobenhoffer J, Schmidt H, Wolf G, Horn TF.

Free Radic Res. 2005 May;39(5):535-45.

PMID:
16036330
11.

Switching immunosuppression from cyclosporine to tacrolimus improves long-term kidney function: a 6-year study.

Hohage H, Welling U, Zeh M, Gerhardt U, Suwelack B.

Transplant Proc. 2005 May;37(4):1898-9.

PMID:
15919497
12.

Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function.

Hohage H, Zeh M, Heck M, Gerhardt UW, Welling U, Suwelack BM.

Transplant Proc. 2005 May;37(4):1748-50.

PMID:
15919453
13.

Cyclosporine and tacrolimus: influence on cardiovascular risk factors.

Hohage H, Hillebrandt U, Welling U, Zeh M, Heck M, Gerhardt UW, Suwelack BM.

Transplant Proc. 2005 Mar;37(2):1036-8.

PMID:
15848615
14.

Conversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors.

Hohage H, Welling U, Heck M, Zeh M, Gerhardt U, Suwelack BM.

Int Immunopharmacol. 2005 Jan;5(1):117-23.

PMID:
15589469
15.

Current understanding of the regulation of methionine biosynthesis in plants.

Hesse H, Kreft O, Maimann S, Zeh M, Hoefgen R.

J Exp Bot. 2004 Aug;55(404):1799-808. Epub 2004 Jul 2. Review.

PMID:
15234989
16.

Engineering of cysteine and methionine biosynthesis in potato.

Nikiforova V, Kempa S, Zeh M, Maimann S, Kreft O, Casazza AP, Riedel K, Tauberger E, Hoefgen R, Hesse H.

Amino Acids. 2002;22(3):259-78. Review.

PMID:
12083069
17.
18.

Solving Medicare reimbursement problems in Connecticut.

Zeh MA.

Clin Nurse Spec. 2001 Jul;15(4):164-6. No abstract available.

PMID:
11855500
19.

Collaboration with psychiatrists in Connecticut.

Minarik PA, Zeh MA, Johnston L.

Clin Nurse Spec. 2001 May;15(3):105-7. No abstract available.

PMID:
11855458
20.

Antisense inhibition of threonine synthase leads to high methionine content in transgenic potato plants.

Zeh M, Casazza AP, Kreft O, Roessner U, Bieberich K, Willmitzer L, Hoefgen R, Hesse H.

Plant Physiol. 2001 Nov;127(3):792-802.

Supplemental Content

Loading ...
Support Center